48 results
DEFM14A
FUSN
Fusion Pharmaceuticals Inc
25 Apr 24
Proxy related to merger
4:13pm
-term plans and strategic opportunities to increase long-term shareholder value, including accessing the U.S. public markets and seeking partnership … of value was compelling compared to the uncertain long-term value creation potential of Fusion’s business.
Opportunity to Realize Additional Value
PREM14A
FUSN
Fusion Pharmaceuticals Inc
10 Apr 24
Preliminary proxy related to merger
4:42pm
advisors, Fusion’s long-term plans and strategic opportunities to increase long-term shareholder value, including accessing the U.S. public markets … that this certainty of value was compelling compared to the uncertain long-term value creation potential of Fusion’s business.
Opportunity to Realize
DEFA14A
9cm0tw01k pfz8a7o
19 Mar 24
Additional proxy soliciting materials
6:25am
8-K
EX-2.1
9eo0 1lqkle
19 Mar 24
Voting and Support Agreement
6:24am
424B5
pn1s1on
19 Jan 24
Prospectus supplement for primary offering
4:10pm
8-K
EX-10.1
uh1fe 6m8cl33
11 May 23
Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates
7:46am